Research and Markets: Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2012

DUBLIN--()--Dublin - Research and Markets (http://www.researchandmarkets.com/research/4rtbvm/vancomycinresista) has announced the addition of Global Markets Direct's new report "Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2012', provides an overview of the Vancomycin-Resistant Enterococcus Faecium Infections therapeutic pipeline. This report provides information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections.

'Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Vancomycin-Resistant Enterococcus Faecium Infections.

- A review of the Vancomycin-Resistant Enterococcus Faecium Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Vancomycin-Resistant Enterococcus Faecium Infections pipeline on the basis of route of administration and molecule type.

- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Keywords

Vancomycin-Resistant Enterococcus Faecium Infections Therapeutic Products under Development, Key Players in Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Vancomycin-Resistant Enterococcus Faecium Infections Pipeline Overview, Vancomycin-Resistant Enterococcus Faecium Infections Pipeline, Vancomycin-Resistant Enterococcus Faecium Infections Pipeline Assessment

For more information visit http://www.researchandmarkets.com/research/4rtbvm/vancomycinresista

Source: Global Markets Direct

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): 353-1-481-1716
Sector: Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): 353-1-481-1716
Sector: Infectious Diseases